News & positions

NEWS UPDATES 27 April 2020

GlaxoSmithKline – Together against COVID-19!

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today announced the creation of the Global HIV and COVID-19 Emergency Response Fund. The £3 million fund will make available critical financial resources for research projects to study the medical and scientific impact COVID-19 is having on people living with HIV.


(Source: ViiV Healthcare)